Sarepta Therapeutics Inc (SRPT)

Quick ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash	US$ in thousands	428,430	966,777	2,115,870	1,502,650	835,080
Short-term investments	US$ in thousands	1,247,820	1,022,600	0	435,923	289,668
Receivables	US$ in thousands	403,058	217,939	152,990	101,340	90,879
Total current liabilities	US$ in thousands	653,659	619,604	452,733	416,026	264,767
Quick ratio		3.18	3.56	5.01	4.90	4.59

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($428,430K + $1,247,820K + $403,058K) ÷ $653,659K
= 3.18

The quick ratio of Sarepta Therapeutics Inc has shown a declining trend over the past five years from 4.59 in 2019 to 3.18 in 2023. This ratio indicates the company's ability to meet its short-term financial obligations with its most liquid assets excluding inventory.

A quick ratio above 1 suggests that the company is sufficiently capable of covering its current liabilities with its quick assets. Sarepta's quick ratio has consistently exceeded this threshold over the years, indicating a strong liquidity position.

However, the gradual decline in the quick ratio may signal a decrease in the company's ability to pay off its short-term obligations with immediate resources. It is essential for investors and stakeholders to monitor this trend closely to ensure the company's liquidity remains robust and sustainable.